Figure 2.
Frax-1036 and Rottlerin co-administration significantly slowed tumor growth in OVCAR-3 xenograft tumors compared to control.
Frax-1036 and Rottlerin co-administration significantly slowed tumor growth in OVCAR-3 xenograft tumors compared to control.